SANGAMO THERAPEUTICS, INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Sangamo Therapeutics, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Sangamo Therapeutics, Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 208M shares, a 17.6% increase year-over-year.
  • Sangamo Therapeutics, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 174M shares, a 13% increase from 2022.
  • Sangamo Therapeutics, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 154M shares, a 6.76% increase from 2021.
  • Sangamo Therapeutics, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 145M shares, a 7.53% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 208M +31.2M +17.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 204M +29.6M +17% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 180M +11.8M +7.01% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 174M +20.1M +13% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 177M +19.1M +12.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 174M +26.2M +17.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 169M +22.3M +15.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 154M +9.78M +6.76% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 158M +12.6M +8.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 148M +4.17M +2.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 146M +3.11M +2.17% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 145M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 145M +4.3M +3.05% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 144M +5.01M +3.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 143M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 141M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 139M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.